Trinity Biotech plc
TRIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79 | $82 | $167 | $149 |
| - Cash | $5 | $4 | $7 | $26 |
| + Debt | $101 | $67 | $72 | $99 |
| Enterprise Value | $175 | $146 | $233 | $223 |
| Revenue | $62 | $57 | $63 | $81 |
| % Growth | 8.3% | -9.1% | -23% | – |
| Gross Profit | $21 | $19 | $22 | $33 |
| % Margin | 34.8% | 34.2% | 35.3% | 41.2% |
| EBITDA | -$17 | -$24 | -$17 | $11 |
| % Margin | -27.5% | -42.4% | -26.7% | 13.1% |
| Net Income | -$32 | -$24 | -$41 | $1 |
| % Margin | -51.6% | -42.3% | -65.6% | 1.1% |
| EPS Diluted | -1.77 | -3.2 | -5.2 | 0.16 |
| % Growth | 44.7% | 38.5% | -3,350% | – |
| Operating Cash Flow | -$4 | -$12 | -$1 | $13 |
| Capital Expenditures | -$10 | -$1 | -$6 | -$9 |
| Free Cash Flow | -$14 | -$12 | -$7 | $5 |